Research News and Research

RSS

Illumina 2010 third quarter revenue increases 50% to $237.3 million

Illumina, Inc. today announced its financial results for the third quarter of 2010.

From Illumina, Inc. 27 Oct 2010

Pledge to reduce antipsychotic use in dementia sufferers

A new coalition of 44 organizations called the Dementia Action Alliance, has called for a cut in the use of anti-psychotic drugs for patients with dementia. The coalition includes Alzheimer's Research Trust, Alzheimer's Society, BUPA, Dementia UK, the Royal College of Psychiatrists, Royal College of General Practitioners and Stroke Association.

26 Oct 2010

Rising alcohol prices driving the young towards illicit drug use

A latest study that spanned over two years revealed a link between alcohol prices and consumption of illicit drugs such as ecstasy. The study says that as alcohol prices have risen young people have ‘switched’ to the party drug ecstasy as an alternative.

26 Oct 2010

Medicare reimbursement changes increase demand for intermittent catheters

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, reimbursement changes have caused the demand for intermittent catheters to increase significantly. In April 2008, Medicare changed reimbursement to cover up to 200 catheters per month, instead of the previous 4 that it covered.

26 Oct 2010

PPD and VirtualScopics partner to provide medical imaging services

PPD, Inc. and VirtualScopics, Inc. today announced a strategic alliance to deliver a comprehensive set of clinical and medical imaging services that will enable biopharmaceutical companies to make faster, more confident decisions on the development of their oncology compounds, creating time and cost efficiencies.

26 Oct 2010

Decision Resources moves global corporate headquarters to larger space in Burlington

Decision Resources, Inc., one of the world's leading research and advisory firms focusing on healthcare insights and analysis, has moved its global corporate headquarters from Waltham, MA to Burlington, MA. The significantly larger office space located at 8 New England Executive Park in Burlington, MA allows the Company to plan for future growth.

26 Oct 2010

Caldera Medical relocates to new, larger facility

Caldera Medical today announced its relocation to a new facility in Agoura Hills, CA. The former corporate headquarters of DTS offers Caldera approximately eight times more square footage in anticipation of continued growth as well as capability expansion.

26 Oct 2010

miRagen and CU enter agreement on miRNA therapeutics discovery and development

miRagen Therapeutics, Inc., a biopharmaceutical company focused on improving patients' lives by developing innovative microRNA (miRNA)-based therapeutics for cardiovascular and muscle disease, and the University of Colorado (CU) announced today that they have entered into sponsored research and licensing agreements to collaborate on miRNA therapeutics discovery and development.

26 Oct 2010

Agile presents AG200-15 contraceptive patch Phase 2 clinical study results at 66th ASRM

Agile Therapeutics announced results today from a Phase 2 clinical study of AG200-15, Agile's weekly contraceptive patch containing ethinyl estradiol (EE) in combination with levonorgestrel (LNG). According to the clinical findings, AG200-15 provides a low daily dose of estrogen equivalent to 30 micrograms EE, similar to that in low-dose, oral contraceptive (OC) pills.

26 Oct 2010

Bristol-Myers Squibb 2010 third quarter U.S. net sales increases 4% to $3.1 billion

Bristol-Myers Squibb Company today reported results for the third quarter of 2010. Highlights in the quarter included: the presentation of new data on investigational compounds in the diabetes and cardiovascular disease franchises at major medical meetings; the completion of important regulatory milestones in the oncology, diabetes and immunoscience franchises; the acquisition of ZymoGenetics; and double-digit EPS growth. The company also confirmed guidance for 2010.

26 Oct 2010

Techne Corporation 2011 first quarter net earnings decreases 1.5% to $26.4 million

Techne Corporation's consolidated net earnings for the quarter ended September 30, 2010 decreased 1.5% to $26.4 million or $.71 per diluted share compared with $26.8 million or $.72 per diluted share for the quarter ended September 30, 2009.

From BiosPacific, Inc. 26 Oct 2010

Racial disparities among children with frequent ear infections can influence access to health care resources

Ear infections are one of the most common health problems for children, with most kids experiencing at least one by their third birthday. Annual costs in the United States alone are in the billions of dollars.

26 Oct 2010

Compugen 2010 third quarter net loss decreases to $1.6 million from $1.9 million

Compugen Ltd. today reported financial results for the third quarter ending September 30, 2010.

26 Oct 2010

First Edition: October 26, 2010

In today's headlines, more reports from the campaign trail -- highlighting how tempers and politics continue to flare around health overhaul issues.

26 Oct 2010

Biogen 2010 third quarter revenue increase 5% to $1.2 billion

Biogen Idec Inc. a global biotechnology leader in the discovery, development, manufacturing, and commercialization of innovative therapies, today announced its third quarter 2010 results.

26 Oct 2010

New findings could deliver low-cost method to extract anticancer compound

A popular cancer drug could be produced cheaply and sustainably using stem cells derived from trees, a study suggests. Researchers have isolated and grown stem cells from a yew tree whose bark is a natural source of the anticancer compound paclitaxel. The development could enable the compound to be produced on a commercial scale at low cost, with no harmful by-products.

26 Oct 2010

India's Trade Minister says EU will take steps to prevent seizure of generic medicines

"India believes a row with the European Union over seizures of generic drugs will be settled without litigation, Trade Minister Anand Sharma said on Wednesday," Reuters reports (Lynn, 10/20).

26 Oct 2010

Kinetic Concepts 2010 third quarter total revenue increases 2% to $506.7 million

Kinetic Concepts, Inc. today reported third quarter 2010 total revenue of $506.7 million compared to $504.4 million in the third quarter of 2009 and up 2% from the second quarter of 2010.

26 Oct 2010

Einstein updates Strategic Research Plan

Albert Einstein College of Medicine of Yeshiva University has updated its Strategic Research Plan, the guidepost by which research priorities for the College of Medicine are set and measured. The update is designed to keep Einstein's research enterprise on course, to determine which investigative areas should be expanded or redirected, and to identify new areas that were underappreciated when the original research plan was formulated.

26 Oct 2010

Research indicates stroma tissue provides new drug target for treating pancreatic cancer

A project focusing on the scar tissue surrounding cancer tumours aims to provide new targets for drugs for treating pancreatic cancer, the fifth highest cause of cancer deaths in the UK.

26 Oct 2010

Research News and Research

Illumina 2010 third quarter revenue increases 50% to $237.3 million

Pledge to reduce antipsychotic use in dementia sufferers

Rising alcohol prices driving the young towards illicit drug use

Medicare reimbursement changes increase demand for intermittent catheters

PPD and VirtualScopics partner to provide medical imaging services

Decision Resources moves global corporate headquarters to larger space in Burlington

Caldera Medical relocates to new, larger facility

miRagen and CU enter agreement on miRNA therapeutics discovery and development

Agile presents AG200-15 contraceptive patch Phase 2 clinical study results at 66th ASRM

Bristol-Myers Squibb 2010 third quarter U.S. net sales increases 4% to $3.1 billion

Techne Corporation 2011 first quarter net earnings decreases 1.5% to $26.4 million

Racial disparities among children with frequent ear infections can influence access to health care resources

Compugen 2010 third quarter net loss decreases to $1.6 million from $1.9 million

First Edition: October 26, 2010

Biogen 2010 third quarter revenue increase 5% to $1.2 billion

New findings could deliver low-cost method to extract anticancer compound

India's Trade Minister says EU will take steps to prevent seizure of generic medicines

Kinetic Concepts 2010 third quarter total revenue increases 2% to $506.7 million

Einstein updates Strategic Research Plan

Research indicates stroma tissue provides new drug target for treating pancreatic cancer

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest Life Science News